HGF and lung cancer: Similarly, HGF treatment of lung cancer derived A549-shScr cells, but not A549-shRan cells, resulted in a significant increase in cell adhesion (Figure 3D; p < 0.05), migration (Figure 3E; p < 0.05), and invasion (Figure 3F; p < 0.05).